Glenmark Pharmaceuticals
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Glenmark House B. D. Sawant Marg Chakala...Phone Number
+91 2240189999Website
www.glenmarkpharma.comRevenue
$1.4 BillionStock Symbol
GLENMARK.NSIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
7
1
2
1
2
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development of innovative medications. Glenmark specializes in various therapeutic areas and maintains a diverse portfolio of pharmaceutical products serving both business and consumer markets worldwide.Explore more
Glenmark Pharmaceuticals Org Chart
SB
BU Research Development Finance Controller & ...
KM
Finance Controller
SP
Caribbean Region Financial Controller
KG
Finance Controller
RG
Finance Administrator & Controller
SP
Caribbean Region Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Glenmark Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Glenmark Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Glenmark Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Glenmark Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Glenmark Pharmaceuticals
Check out if Glenmark Pharmaceuticals is spiking on competitors!
Check if Glenmark Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Glenmark Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Glenmark Pharmaceuticals recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Glenmark Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Glenmark Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Glenmark Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Glenmark Pharmaceuticals.
Glenmark Pharmaceuticals financials insights
Gather financial insights about Glenmark Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2002
Private Equity
$48M
2015
Other Financing Round
$150M
2016
Debt
$200M
2020
Debt
$200M
Glenmark Pharmaceuticals Tech Stack
A closer look at the technologies used by Glenmark Pharmaceuticals
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Product Launch, Pharmaceuticals
Person-Based
Pharmaceuticals
Person-Based
Pharmaceuticals, Regulations
Hiring Plans
Hiring Plans
Glenmark Pharmaceuticals News & Media
Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative Portfolio
RYALTRIS® is Glenmark's first innovative product introduced into the U.S. market ELMWOOD PARK, N.J., April 1, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced that it will manage end-to-end commercialization and distribution for RYALTRIS® (Olopatadine...Glenmark Pharmaceuticals Canada Inc. Launches Men's GLN-Minoxidil 5% w/w Topical Aerosol Foam in Canadian Retail
Strengthens OTC portfolio with affordable hair regrowth solution for Men CONCORD, Ontario, March 31, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Canada Inc. announced the launch of Men's GLN-Minoxidil 5% w/w (50 mg/g) Topical Aerosol Foam in Canada, expanding its OTC portfolio with a...Glenmark launches potassium phosphates injection
Potassium phosphates injection had a market value of approximately $50.7 million for the 12 months ending January 2026, per IQVIA.Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity
ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. Glenmark's Fluticasone Propionate Inhalation...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glenmark Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development o... Read More
